Cargando…
A Low-Toxicity DNA-Alkylating N-Mustard-Quinoline Conjugate with Preferential Sequence Specificity Exerts Potent Antitumor Activity Against Colorectal Cancer
Efficacy and safety are fundamental prerequisites for anticancer drug development. In the present study, we explored the anti–colorectal cancer (CRC) activity of SL-1, a DNA-directed N-mustard-quinoline conjugate. The N-mustard moiety in SL-1 induced DNA strand breaks, interstrand cross-links (ICLs)...
Autores principales: | Chen, Tai-Lin, Lin, Yi-Wen, Chen, Yan-Bo, Lin, Jing-Jer, Su, Tsann-Long, Shen, Chia-Ning, Lee, Te-Chang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5884014/ https://www.ncbi.nlm.nih.gov/pubmed/29247884 http://dx.doi.org/10.1016/j.neo.2017.11.006 |
Ejemplares similares
-
Nanozyme hydrogel for enhanced alkyl radical generation and potent antitumor therapy
por: Ning, Shipeng, et al.
Publicado: (2022) -
ICAM1 antibody drug conjugates exert potent antitumor activity in papillary and anaplastic thyroid carcinoma
por: Zhang, Peng, et al.
Publicado: (2023) -
Furan-Conjugated Tripeptides as Potent Antitumor Drugs
por: Ali, Hunain, et al.
Publicado: (2020) -
Enhancement of radiosensitivity in human glioblastoma cells by the DNA N-mustard alkylating agent BO-1051 through augmented and sustained DNA damage response
por: Chu, Pei-Ming, et al.
Publicado: (2011) -
Derivatives of 6-cinnamamido-quinoline-4-carboxamide impair lysosome function and induce apoptosis
por: Kuo, Hsiao-Hui, et al.
Publicado: (2016)